Developer docs
API playgroundTry for free, no card

Search company profiles

The Jackson Laboratory

Full company profile

uuid0000cx4

Namestring
The Jackson Laboratory
Legal namestring
The Jackson Laboratory
Websiteurl
jax.org
Company typeenum
Private
Founded yearint
1929
Descriptiontext

The Jackson Laboratory (JAX) is an independent, nonprofit biomedical research institution founded in 1929 and headquartered in Bar Harbor, Maine, with additional campuses in Farmington, Connecticut; Sacramento, California; and Yokohama, Japan, and a workforce of nearly 3,000 employees. The organization's core product is JAX® Mice—a portfolio of genetically engineered, humanized, and standard inbred mouse strains used by academic researchers, pharmaceutical companies, and biotech firms for preclinical drug discovery and disease research—supported by complementary services including preclinical research, custom model generation, colony management, and patient-derived xenograft (PDX) models. JAX maintains two internationally recognized databases: Mouse Genome Informatics (MGI) and the Mouse Phenome Database (MPD), which together form the standard reference resources for laboratory mouse research and are licensed under Creative Commons Attribution 4.0.

JAX generates revenue through multiple streams: direct sales of mouse models via mice.jax.org and customer support lines (pay-as-you-go unit pricing); preclinical and contract research services; federal and foundation research grants (including a $30M ARPA-H contract for the CARDIOVERSE AI drug-safety project, NIH funding, and a $1.8M Michael J. Fox Foundation grant); licensing of models and technologies; and educational program fees including $15 digital credential badges for JAX MicroLessons and MiniCourses (free content layer with paid certification). Following the October 2025 acquisition of the New York Stem Cell Foundation (NYSCF), the JAX-NYSCF Collaborative extends the institution into stem cell technologies and automation, with major recent partnerships including a five-year GSK collaboration on Alzheimer's and neurodegenerative disease human cellular models and a UConn Health partnership for methylome-based CNS tumor diagnostics. JAX is also an NCI-designated Cancer Center and operates a substantial K-12 and professional education platform (Teaching the Genome Generation™, Summer Student Program, JAX MicroLessons/MiniCourses) that has reached nearly 25,000 students across nine states and trained 310+ educators since 2014.

Short descriptiontext

The Jackson Laboratory is a nonprofit biomedical research institution founded in 1929 that develops genetically engineered and humanized mouse models, preclinical research services, and educational programs for pharmaceutical, biotech, and academic researchers worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersBar Harbor, United States
HQ citystring
Bar Harbor
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mouse model research, preclinical research services, biomedical research institution, genomics education programs, stem cell technologies
Industry4 codes
1Central Laboratory Services (Core Lab Operations)
CodeHLAGAEAAPrimaryYes
2Molecular Diagnostics & Genomics Laboratories
CodeHLAFAMAEPrimaryNo
3AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening)
CodeHLAAAIAEPrimaryNo
4Laboratory Informatics & Reporting (LIMS/ELR) Public Health Networks
CodeHLAJAIANPrimaryNo
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
Product category
Biomedical Research Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Mouse Model Sales
TypeOne Time License
Description

Sale of JAX mouse models including genetically engineered, humanized, and standard strains to academic and pharmaceutical researchers worldwide.

jax.org
2Preclinical Research Services
TypeProfessional Services
Description

Contract research services including colony management, custom model generation, and preclinical testing using mouse models.

jax.org
3Educational Programs
TypeSubscription Recurring
Description

Revenue from educational offerings including courses, training programs, digital credentials, and summer programs for students and professionals.

jax.org
4Government Research Contracts
TypeProfessional Services
Description

Federal contracts such as the $30M ARPA-H CARDIOVERSE project for drug safety testing development.

prnewswire.com
5Licensing and Technology Transfer
TypeLicensing Royalties
Description

Revenue from licensing mouse models, technologies, and data resources developed at JAX to pharmaceutical and biotech companies.

jax.org
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components2 values
Personnel, Technology or R&D
Pricing details3 tiers
1Mouse Model Sales - Pricing varies by strain and availability
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Orders placed through mice.jax.org; customer support available for quotes and bulk orders.

jax.org
2Digital Credentials and Certificates
ModelOtherBilling cadencePay-as-you-go
Notes

JAX digital badge credential and certificate available for $15 USD upon successful course completion.

education.learning.jax.org
3Free Educational Content
ModelFreemiumBilling cadencePay-as-you-go
Notes

MicroLessons (15 minutes) and MiniCourses (1-2 hours) available free; only credential/badge issuance has a fee.

education.learning.jax.org
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Jackson Laboratory is an independent, nonprofit biomedical research institution that develops, breeds, and distributes genetically engineered and humanized mouse models for academic, pharmaceutical, and biotechnology researchers worldwide. It provides preclinical research services, custom model generation, and colony management to de-risk drug development, and delivers educational programs and digital credentials for students, teachers, and scientific professionals. Following its 2025 acquisition of the New York Stem Cell Foundation, JAX now also offers stem cell technologies and AI-powered research platforms such as the ARPA-H funded CARDIOVERSE virtual heart project.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • CARDIOVERSE project aims to reduce animal studies through AI-powered virtual heart models
+3 more records
Product overview1 text field

The Jackson Laboratory operates as a nonprofit biomedical research organization offering a comprehensive portfolio of products and services centered on mouse models, genomic research, and education. The core offerings include JAX® Mice (including humanized mouse models and patient-derived xenograft models), the Mouse Phenome Database (MPD) for phenotypic data, and Mouse Genome Informatics (MGI) for genetic/genomic data. Supporting services include Preclinical Research Services, Custom Model Generation, and Colony Management. Following the NYSCF acquisition, JAX-NYSCF Collaborative now provides stem cell technologies and automation capabilities. Educational offerings span from K-12 programs (Summer Student Program, Teaching the Genome Generation™) to professional development (JAX Online MicroLessons and MiniCourses). Major technology initiatives include the ARPA-H funded CARDIOVERSE project using AI-powered virtual hearts for drug safety testing, GSK partnership for human cellular models in neurodegenerative disease research, and digital twin models for oncology. The organization operates research campuses in Maine, Connecticut, California, and Japan.

Product and service1 record
1JAX® Mice & Services
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-11
Description

Partnership to create digital versions of Teaching the Genome Generation laboratory protocols, expanding accessibility through virtual labs, interactives on genetic variation, PCR, RFLP, and sequencing for high school students globally.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-02-17
Description

Five-year research collaboration between JAX-NYSCF Collaborative and GSK to develop human cellular models for neurodegenerative diseases, including Alzheimer's disease. Leverages stem cell technology and data science to create predictive models for drug discovery and accelerate development of therapies for neurodegenerative conditions.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-05
Description

Partnership between UConn Health's Department of Neurosurgery and Department of Pathology and Laboratory Medicine with JAX for Genomic Medicine to validate and offer methylome profiling for brain and spine tumor diagnosis. One of only four US locations with this capability.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-20
Description

JAX completed acquisition of NYSCF, creating a unified nonprofit biomedical research organization. Integration combines JAX's genetics and mouse models expertise with NYSCF's stem cell and automation technologies to enhance disease research and therapy development.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global CRO providing research models and preclinical services. Direct competitor in supplying laboratory mice and offering preclinical research services to pharma and academia, overlapping with JAX Mice and Preclinical Research Services.

TypeDirect peer
Description

Leading supplier of genetically engineered mouse and rat models and related services. Direct peer to JAX Mice business, competing on model generation, colony management, and humanized models.

TypeDirect peer
Description

Provider of research models and preclinical research services following the Envigo-Harlan combination. Competes with JAX across mouse model supply and contract research services.

4The Jackson Laboratory (Japan) office competes regionally; internationally, Cyagen Biosciences offers similar custom mouse model generation services.
TypeEmerging player
Description

Specialist mouse model generation and preclinical CRO with global footprint in custom genetically engineered models. Comparable to JAX's Custom Model Generation and preclinical offerings, especially for academic and biotech clients.

TypeDirect peer
Description

Preclinical CRO specializing in oncology and immuno-oncology models including PDX and humanized mice. Direct peer to JAX's PDX and preclinical oncology research services.

TypeBroad incumbent
Description

Global CRO/CDMO offering preclinical services, animal models, and biologics discovery. Broadly comparable to JAX preclinical research services and a larger, more diversified peer in the same customer base.

TypeDirect peer
Description

Nonprofit biomedical research institution focused on cancer, neuroscience, and quantitative biology. Comparable as a peer nonprofit research organization with overlapping disease focus areas and education programs.

TypeDirect peer
Description

Nonprofit genomics research institute affiliated with MIT/Harvard. Comparable peer in genomic medicine, AI-driven biology, and translational research collaborations with pharma.

TypeBroad incumbent
Description

Independent nonprofit research organization focused on cancer, neuroscience, and plant biology. Comparable as a peer nonprofit research institution of similar scale and reputation.

TypeBroad incumbent
Description

Independent nonprofit bioscience research organization producing large-scale public datasets and tools. Comparable peer in nonprofit research model, data resources (atlas-style), and AI applications to biology.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds22 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Jackson Laboratory

Biomedical Research Servicesjax.org

The Jackson Laboratory is a nonprofit biomedical research institution founded in 1929 that develops genetically engineered and humanized mouse models, preclinical research services, and educational programs for pharmaceutical, biotech, and academic researchers worldwide.

What The Jackson Laboratory does

The Jackson Laboratory (JAX) is an independent, nonprofit biomedical research institution founded in 1929 and headquartered in Bar Harbor, Maine, with additional campuses in Farmington, Connecticut; Sacramento, California; and Yokohama, Japan, and a workforce of nearly 3,000 employees. The organization's core product is JAX® Mice—a portfolio of genetically engineered, humanized, and standard inbred mouse strains used by academic researchers, pharmaceutical companies, and biotech firms for preclinical drug discovery and disease research—supported by complementary services including preclinical research, custom model generation, colony management, and patient-derived xenograft (PDX) models. JAX maintains two internationally recognized databases: Mouse Genome Informatics (MGI) and the Mouse Phenome Database (MPD), which together form the standard reference resources for laboratory mouse research and are licensed under Creative Commons Attribution 4.0.

JAX generates revenue through multiple streams: direct sales of mouse models via mice.jax.org and customer support lines (pay-as-you-go unit pricing); preclinical and contract research services; federal and foundation research grants (including a $30M ARPA-H contract for the CARDIOVERSE AI drug-safety project, NIH funding, and a $1.8M Michael J. Fox Foundation grant); licensing of models and technologies; and educational program fees including $15 digital credential badges for JAX MicroLessons and MiniCourses (free content layer with paid certification). Following the October 2025 acquisition of the New York Stem Cell Foundation (NYSCF), the JAX-NYSCF Collaborative extends the institution into stem cell technologies and automation, with major recent partnerships including a five-year GSK collaboration on Alzheimer's and neurodegenerative disease human cellular models and a UConn Health partnership for methylome-based CNS tumor diagnostics. JAX is also an NCI-designated Cancer Center and operates a substantial K-12 and professional education platform (Teaching the Genome Generation™, Summer Student Program, JAX MicroLessons/MiniCourses) that has reached nearly 25,000 students across nine states and trained 310+ educators since 2014.

The Jackson Laboratory firmographics

Firmographics
Name
The Jackson Laboratory
Legal name
The Jackson Laboratory
Website
https://jax.org
Company type
Private
Founded year
1929
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
The Jackson Laboratory is a nonprofit biomedical research institution founded in 1929 that develops genetically engineered and humanized mouse models, preclinical research services, and educational programs for pharmaceutical, biotech, and academic researchers worldwide.
Ownership category
akta.pro rank

The Jackson Laboratory industry classification

Industry
Product category
Biomedical Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro primary industry
Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
akta.pro secondary industries
Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE), Laboratory Informatics & Reporting (LIMS/ELR) Public Health Networks (HLAJAIAN)

Keywords

  • Mouse model research
  • Preclinical research services
  • Biomedical research institution
  • Genomics education programs
  • Stem cell technologies

Where The Jackson Laboratory is headquartered

Location

Headquarters

HQ city
Bar Harbor
HQ country
United States
HQ region
North America

Offices4 records

Markets served

The Jackson Laboratory business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D

Revenue model

  1. Mouse Model Sales: Sale of JAX mouse models including genetically engineered, humanized, and standard strains to academic and pharmaceutical researchers worldwide.
  2. Preclinical Research Services: Contract research services including colony management, custom model generation, and preclinical testing using mouse models.
  3. Educational Programs: Revenue from educational offerings including courses, training programs, digital credentials, and summer programs for students and professionals.
  4. Government Research Contracts: Federal contracts such as the $30M ARPA-H CARDIOVERSE project for drug safety testing development.
  5. Licensing and Technology Transfer: Revenue from licensing mouse models, technologies, and data resources developed at JAX to pharmaceutical and biotech companies.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goMouse Model Sales - Pricing varies by strain and availability
OtherPay-as-you-goDigital Credentials and Certificates
FreemiumPay-as-you-goFree Educational Content

Go-to-market motion3 records

Distribution channels5 records

Marketing channels9 records

The Jackson Laboratory product offering

Product offering

Core offering

The Jackson Laboratory is an independent, nonprofit biomedical research institution that develops, breeds, and distributes genetically engineered and humanized mouse models for academic, pharmaceutical, and biotechnology researchers worldwide. It provides preclinical research services, custom model generation, and colony management to de-risk drug development, and delivers educational programs and digital credentials for students, teachers, and scientific professionals. Following its 2025 acquisition of the New York Stem Cell Foundation, JAX now also offers stem cell technologies and AI-powered research platforms such as the ARPA-H funded CARDIOVERSE virtual heart project.

Product overview

The Jackson Laboratory operates as a nonprofit biomedical research organization offering a comprehensive portfolio of products and services centered on mouse models, genomic research, and education. The core offerings include JAX® Mice (including humanized mouse models and patient-derived xenograft models), the Mouse Phenome Database (MPD) for phenotypic data, and Mouse Genome Informatics (MGI) for genetic/genomic data. Supporting services include Preclinical Research Services, Custom Model Generation, and Colony Management. Following the NYSCF acquisition, JAX-NYSCF Collaborative now provides stem cell technologies and automation capabilities. Educational offerings span from K-12 programs (Summer Student Program, Teaching the Genome Generation™) to professional development (JAX Online MicroLessons and MiniCourses). Major technology initiatives include the ARPA-H funded CARDIOVERSE project using AI-powered virtual hearts for drug safety testing, GSK partnership for human cellular models in neurodegenerative disease research, and digital twin models for oncology. The organization operates research campuses in Maine, Connecticut, California, and Japan.

Differentiator

Problem solved

Functional benefit

Products and services

  • JAX® Mice & Services

Quantifiable outcome

  • CARDIOVERSE project aims to reduce animal studies through AI-powered virtual heart models
  • +3 more outcomes

Companies that use The Jackson Laboratory

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles4 records

The Jackson Laboratory technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature6 records

The Jackson Laboratory partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and flagship.

  • LabXchangecoreStrategic or Co-development Partner · 11 March 2026Partnership to create digital versions of Teaching the Genome Generation laboratory protocols, expanding accessibility through virtual labs, interactives on genetic variation, PCR, RFLP, and sequencing for high school students globally.
  • GSKflagshipStrategic or Co-development Partner · 17 February 2026Five-year research collaboration between JAX-NYSCF Collaborative and GSK to develop human cellular models for neurodegenerative diseases, including Alzheimer's disease. Leverages stem cell technology and data science to create predictive models for drug discovery and accelerate development of therapies for neurodegenerative conditions.
  • UConn HealthcoreStrategic or Co-development Partner · 5 February 2026Partnership between UConn Health's Department of Neurosurgery and Department of Pathology and Laboratory Medicine with JAX for Genomic Medicine to validate and offer methylome profiling for brain and spine tumor diagnosis. One of only four US locations with this capability.
  • New York Stem Cell Foundation (NYSCF)coreStrategic or Co-development Partner · 20 October 2025JAX completed acquisition of NYSCF, creating a unified nonprofit biomedical research organization. Integration combines JAX's genetics and mouse models expertise with NYSCF's stem cell and automation technologies to enhance disease research and therapy development.

Scale indicators9 records

Recent moves7 records

Expansion highlights7 records

The Jackson Laboratory competitors and assessment

Company assessment

Direct peers

  • Charles River Laboratories: Global CRO providing research models and preclinical services. Direct competitor in supplying laboratory mice and offering preclinical research services to pharma and academia, overlapping with JAX Mice and Preclinical Research Services.
  • Taconic Biosciences: Leading supplier of genetically engineered mouse and rat models and related services. Direct peer to JAX Mice business, competing on model generation, colony management, and humanized models.
  • Envigo (Inotiv): Provider of research models and preclinical research services following the Envigo-Harlan combination. Competes with JAX across mouse model supply and contract research services.
  • Crown Bioscience: Preclinical CRO specializing in oncology and immuno-oncology models including PDX and humanized mice. Direct peer to JAX's PDX and preclinical oncology research services.
  • Cold Spring Harbor Laboratory: Nonprofit biomedical research institution focused on cancer, neuroscience, and quantitative biology. Comparable as a peer nonprofit research organization with overlapping disease focus areas and education programs.
  • Broad Institute: Nonprofit genomics research institute affiliated with MIT/Harvard. Comparable peer in genomic medicine, AI-driven biology, and translational research collaborations with pharma.

Emerging players

  • The Jackson Laboratory (Japan) office competes regionally; internationally, Cyagen Biosciences offers similar custom mouse model generation services. Specialist mouse model generation and preclinical CRO with global footprint in custom genetically engineered models. Comparable to JAX's Custom Model Generation and preclinical offerings, especially for academic and biotech clients.

Broad incumbents

  • WuXi AppTec: Global CRO/CDMO offering preclinical services, animal models, and biologics discovery. Broadly comparable to JAX preclinical research services and a larger, more diversified peer in the same customer base.
  • Salk Institute for Biological Studies: Independent nonprofit research organization focused on cancer, neuroscience, and plant biology. Comparable as a peer nonprofit research institution of similar scale and reputation.
  • Allen Institute: Independent nonprofit bioscience research organization producing large-scale public datasets and tools. Comparable peer in nonprofit research model, data resources (atlas-style), and AI applications to biology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

The Jackson Laboratory social profiles

Digital presence

The Jackson Laboratory financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Jackson Laboratory leadership team

Management profile

Number of profiles

Profiles9 records

The Jackson Laboratory subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

The Jackson Laboratory funding detail

Funding detail

Funding overview

Funding rounds22 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Jackson Laboratory M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Jackson Laboratory

What does The Jackson Laboratory do?

The Jackson Laboratory is an independent, nonprofit biomedical research institution that develops, breeds, and distributes genetically engineered and humanized mouse models for academic, pharmaceutical, and biotechnology researchers worldwide. It provides preclinical research services, custom model generation, and colony management to de-risk drug development, and delivers educational programs and digital credentials for students, teachers, and scientific professionals. Following its 2025 acquisition of the New York Stem Cell Foundation, JAX now also offers stem cell technologies and AI-powered research platforms such as the ARPA-H funded CARDIOVERSE virtual heart project.

Is The Jackson Laboratory a public or private company?

The Jackson Laboratory is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was The Jackson Laboratory founded?

The Jackson Laboratory was founded in 1929. It employs 1,001 to 5,000 people.

Where is The Jackson Laboratory based?

The Jackson Laboratory is headquartered in Bar Harbor, United States, in the North America region.

How does The Jackson Laboratory make money?

Five revenue lines are on record. Mouse Model Sales are the primary driver. The others are preclinical Research Services, educational Programs, government Research Contracts and licensing and Technology Transfer.

Who are The Jackson Laboratory's main competitors?

Direct peers on record are Charles River Laboratories, Taconic Biosciences, Envigo (Inotiv), Crown Bioscience, Cold Spring Harbor Laboratory and Broad Institute. The Jackson Laboratory (Japan) office competes regionally; internationally, Cyagen Biosciences offers similar custom mouse model generation services. is listed as an emerging player. Broad incumbents are WuXi AppTec, Salk Institute for Biological Studies and Allen Institute.

Does The Jackson Laboratory have an API?

No public API is recorded for The Jackson Laboratory.

What industry is The Jackson Laboratory in?

The Jackson Laboratory's product category is Biomedical Research Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAFAMAE, Molecular Diagnostics & Genomics Laboratories. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mirage NewsPostdocs Speak For Science At 10th Annual Research DayPostdoctoral researchers from UConn Health and Jackson Laboratories competed in a four-minute presentation competition on Sept. 17. The event, held for the 10th year, featured 22 research topics and three winners, with the largest attendance ever recorded.Mirage NewsPre-Cancer Blood Cells May Age Bone Marrow, Boost RiskResearchers at The Jackson Laboratory published in Nature Cell Biology that pre-cancerous blood cells in clonal hematopoiesis actively age nearby bone marrow stromal cells, creating an environment that favors their expansion. Clearing senescent support cells reduced mutant clone growth and slowed progression to blood cancer in mouse models. The team plans to test similar mechanisms in other tissues.Bangor Daily NewsJackson Lab denies knowledge of former employee’s sexual harassment claimsThe Jackson Laboratory has denied allegations from a former employee who filed a federal lawsuit claiming the lab failed to address sexual harassment by coworker Brandon Lyons. The lab asserts it took reasonable care to prevent discrimination and cites unclean hands, while Lyons faces criminal charges for planting a hidden camera in a laboratory bathroom.NBC ConnecticutBeyond the Scale: Endometriosis patients report relief after using GLP-1sDoctors and patients in the United States are exploring GLP-1 medications, such as tirzepatide, as an off-label treatment for endometriosis symptoms after traditional therapies failed. Clinical observations indicate that low-dose GLP-1 usage reduces inflammation and improves quality of life for some patients, prompting UConn Health and the Jackson Laboratory to initiate research into the connection.PR NewswireBroad Institute, Boston Children's Hospital, and The Jackson Laboratory launch the Center for Therapeutic Genetics, a non-profit effort to develop genetic medicines for rare and ultra-rare diseasesBroad Institute, Boston Children's Hospital, and The Jackson Laboratory have launched the Center for Therapeutic Genetics (CTG), a non-profit collaboration to develop genetic medicines for rare and ultra-rare diseases using base and prime editing technologies as a repeatable clinical practice rather than one-off treatments. The center, which has received up to $34.5 million from the ARPA-H THRIVE program, will share its methods, data, and training infrastructure across institutions to make precision genetic medicine faster, safer, and more accessible. The initiative addresses a significant unmet need, as approximately 350–400 million people worldwide are affected by one of roughly 8,000 rare diseases, yet fewer than one in 20 has an approved treatment.The New York Times‘Too Rare to Care’? A New Center for Rare Diseases Hopes to Change ThatResearchers from the Broad Institute, Boston Children's Hospital, and the Jackson Laboratory announced the launch of a new nonprofit, the Center for Therapeutic Genetics, to develop reusable gene therapy treatments for rare diseases, moving away from the current bespoke drug model where each treatment requires starting from scratch. The center received a $34.5 million contract from the federal Advanced Research Projects Agency for Health (ARPA-H) and will initially focus on neurological disorders causing seizures, with the goal of demonstrating how a single editing system can be adapted across multiple genetic brain diseases. The project aims to address the industry problem of ultrarare diseases being dismissed as "too rare to care" due to prohibitive development costs, potentially benefiting the 400 million people worldwide affected by rare diseases.STATBroad Institute, partners unveil new initiative to develop gene therapies for rare diseasesThe Broad Institute, Boston Children's Hospital, and Maine's Jackson Laboratory announced a collaboration to develop gene therapies for rare diseases and make them cheaper and more accessible. The new non-profit Center for Therapeutic Genetics will create precision medicines and share methods, data, and training with clinicians. The goal is to make personalized treatments more like clinical procedures, avoiding separate regulatory approvals for each use.FierceBiotechGenetic medicine luminaries launch new center for personalized therapiesA team of veteran scientists from elite institutions including Harvard, Boston Children's Hospital, and The Jackson Laboratory has launched the Center for Therapeutic Genetics (CTG), a nonprofit dedicated to developing personalized genetic medicines for infants with rare genetic diseases. The new center, which will initially focus on custom gene therapies for severe childhood epilepsies, was founded in response to the groundbreaking custom CRISPR treatment for Baby KJ and is being funded by ARPA-H. CTG aims to create a standardized procedural approach to treating genetic diseases, similar to surgery, though founders acknowledge this vision remains distant and that securing insurance reimbursement remains a key challenge.BioSpaceThe Jackson Laboratory, with the Broad Institute and Partners, Selected for ARPA-H THRIVE Award to Advance Gene Editing Platform for Pediatric Epilepsies and Rare CNS DiseasesThe Jackson Laboratory and the Broad Institute were selected for an up to $34.5 million ARPA-H THRIVE award to advance a gene-editing platform for pediatric epilepsies and rare CNS diseases. The project will focus on alternating hemiplegia of childhood and Dravet syndrome, aiming to build a scalable platform for precision genetic medicines.MainebizJackson Lab wins research grant from Michael J. Fox FoundationJackson Laboratory received a $1.8 million grant from the Michael J. Fox Foundation to study Parkinson's disease. The research will be conducted through a collaboration with the New York Stem Cell Foundation and McGill University, aiming to standardize human cell modeling systems to link genetic changes to disease risk.